Parkinson's disease: an investigation of exercise capacity, respiratory function, and gait
- PMID: 9041903
- DOI: 10.1016/s0003-9993(97)90264-1
Parkinson's disease: an investigation of exercise capacity, respiratory function, and gait
Abstract
Objective: To evaluate the exercise capacity of subjects with mild to moderate Parkinson's disease and determine whether abnormalities in respiratory function and gait affect exercise capacity.
Design: Descriptive. Subjects were categorized according to exercise history, disease severity, and presence/absence of upper airway obstruction.
Subjects and setting: Sixteen volunteers with mild to moderate idiopathic Parkinson's disease attended a university research laboratory.
Main outcome measures: Subjects performed a maximum exercise test on a cycle ergometer, together with respiratory function tests and a walking test. Peak values for oxygen consumption and work rate were recorded for the maximum exercise test. Measures of respiratory function included spirometry, flow-volume loops, lung volumes, and mouth pressures. Velocity, stride length, and cadence were measured for preferred and fast speeds of walking. The values obtained on each of these tests were compared with published predicted age- and gender-matched normal values.
Results: Peak oxygen consumptions and peak work loads achieved by subjects with Parkinson's disease were not significantly different from normal values, despite evidence of respiratory and gait abnormalities typical of Parkinson's disease. Exercise category was significantly correlated with percent predicted VO2peak (r = .64, p < .01), with sedentary subjects producing lower scores than exercising subjects. There was no significant correlation between disease severity and percent predicted VO2peak.
Conclusion: Despite their neurological deficit, individuals with mild to moderate Parkinson's disease have the potential to maintain normal exercise capacity with regular aerobic exercise.
Similar articles
-
Effects of respiratory muscle weakness on daily living function, quality of life, activity levels, and exercise capacity in mild to moderate Parkinson's disease.Am J Phys Med Rehabil. 2004 Aug;83(8):601-7. doi: 10.1097/01.phm.0000133436.61009.02. Am J Phys Med Rehabil. 2004. PMID: 15277961
-
Effect of Aerobic Exercise on Cardiopulmonary Responses and Predictors of Change in Individuals With Parkinson's Disease.Arch Phys Med Rehabil. 2021 May;102(5):925-931. doi: 10.1016/j.apmr.2020.12.011. Epub 2021 Jan 14. Arch Phys Med Rehabil. 2021. PMID: 33453190 Clinical Trial.
-
The pathogenesis of gait hypokinesia in Parkinson's disease.Brain. 1994 Oct;117 ( Pt 5):1169-81. doi: 10.1093/brain/117.5.1169. Brain. 1994. PMID: 7953597
-
Exercise Guidelines for Gait Function in Parkinson's Disease: A Systematic Review and Meta-analysis.Neurorehabil Neural Repair. 2018 Oct;32(10):872-886. doi: 10.1177/1545968318801558. Epub 2018 Sep 28. Neurorehabil Neural Repair. 2018. PMID: 30265211
-
Cardiopulmonary Function and Aerobic Exercise in Parkinson's: A Systematic Review of the Literature.Mov Disord Clin Pract. 2020 Jul 25;7(6):599-606. doi: 10.1002/mdc3.13011. eCollection 2020 Aug. Mov Disord Clin Pract. 2020. PMID: 32775504 Free PMC article. Review.
Cited by
-
Asymmetrical pedaling patterns in Parkinson's disease patients.Clin Biomech (Bristol). 2014 Dec;29(10):1089-94. doi: 10.1016/j.clinbiomech.2014.10.006. Epub 2014 Oct 29. Clin Biomech (Bristol). 2014. PMID: 25467810 Free PMC article.
-
Energy cost of spontaneous walking in Parkinson's disease patients.Neurol Sci. 2012 Aug;33(4):779-84. doi: 10.1007/s10072-011-0827-6. Epub 2011 Nov 1. Neurol Sci. 2012. PMID: 22042531
-
No increased risk of obstructive sleep apnea in Parkinson's disease.Mov Disord. 2010 Oct 15;25(13):2246-9. doi: 10.1002/mds.23231. Mov Disord. 2010. PMID: 20669289 Free PMC article.
-
Effects of therapeutic Tai chi on functional fitness and activities of daily living in patients with Parkinson disease.J Exerc Rehabil. 2016 Oct 31;12(5):499-503. doi: 10.12965/jer.1632654.327. eCollection 2016 Oct. J Exerc Rehabil. 2016. PMID: 27807532 Free PMC article.
-
The orphan nuclear receptor Nurr1 agonist amodiaquine mediates neuroprotective effects in 6-OHDA Parkinson's disease animal model by enhancing the phosphorylation of P38 mitogen-activated kinase but not PI3K/AKT signaling pathway.Metab Brain Dis. 2021 Apr;36(4):609-625. doi: 10.1007/s11011-021-00670-2. Epub 2021 Jan 28. Metab Brain Dis. 2021. PMID: 33507465
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical